Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs199637578 | chr20:6028264 | T/C | 0 | 178 | 25.47 | 23.53 | 2.93 | KM Plot |
PCPG | rs1998289 | chr10:101491020 | A/G | 9.3E-5 | 178 | 23.48 | 29.62 | 17.88 | KM Plot |
PCPG | rs1998290 | chr10:101491236 | G/A | 9.93E-5 | 177 | 17.88 | 29.62 | 23.43 | KM Plot |
PCPG | rs199939820 | chr3:80592962 | AT/A | 0.000142 | 175 | 19.87 | 24.03 | 27.4 | KM Plot |
PCPG | rs199967019 | chr2:24335870 | T/TCG | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs200071804 | chr17:1410956 | TCCC/T | 1.46E-5 | 174 | 25.05 | 25 | 25.17 | KM Plot |
PCPG | rs200161277 | chr16:71740172 | C/CTATGT | 9.25E-6 | 174 | 24.23 | 32.03 | 14.5 | KM Plot |
PCPG | rs200189730 | chr2:118667673 | A/AT | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs200291405 | chr2:24335877 | G/GT | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs2004412 | chr11:18158347 | A/T | 8.87E-5 | 176 | 27.23 | 23.48 | 8.33 | KM Plot |
PCPG | rs200494253 | chr2:118541216 | C/T | 1.67E-5 | 177 | 24.85 | 30.33 | 11.65 | KM Plot |
PCPG | rs200518149 | chr2:118524269 | G/T | 1.99E-5 | 174 | 25.08 | 30.63 | 11.65 | KM Plot |
PCPG | rs200523802 | chr3:195792272 | C/CA | 5.61E-8 | 170 | 24.5 | 29.43 | 15.35 | KM Plot |
PCPG | rs200780987 | chr2:118565973 | C/T | 1.77E-5 | 177 | 25.28 | 25.97 | 11.65 | KM Plot |
PCPG | rs200784236 | chr16:56469739 | T/TTAC | 0.000204 | 177 | 25.17 | 26.97 | 36.37 | KM Plot |